Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia

被引:49
|
作者
Favilla, Vincenzo [1 ]
Cimino, Sebastiano [1 ]
Castelli, Tommaso [1 ]
Madonia, Massimo [1 ]
Barbagallo, Ignazio [2 ]
Morgia, Giuseppe [1 ]
机构
[1] Univ Catania, Dept Urol, Catania, Italy
[2] Univ Messina, Dept Biol Chem Med Chem & Mol Biol, I-98100 Messina, Italy
关键词
lower urinary tract symptoms; sex hormones; benign prostatic hyperplasia; STEROID-HORMONES; AGING MEN; OLDER MEN; TESTOSTERONE; PREVALENCE; AGE; BLADDER; FINASTERIDE; COMMUNITY; ESTROGEN;
D O I
10.1111/j.1464-410X.2010.09459.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES To investigate a possible association between the severity of lower urinary tract symptoms (LUTS) and the serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia (BPH) that underwent surgery for severe benign prostatic obstruction. PATIENTS AND METHODS In all, 127 selected men with symptomatic BPH attending our urology clinic were recruited. The clinical conditions of BPH were assessed by digital rectal examination, serum prostate-specific antigen (PSA) determination, International Prostate Symptom Score (IPSS), transrectal ultrasonography and maximum urinary flow rate (Q(max)) value at uroflussimetry. Before surgery, we measured the serum concentrations of total testosterone (TT) and free testosterone (FT), oestradiol, prolactin, luteinizing hormone and follicle-stimulating hormone. We excluded men with endocrine diseases, those with prostate disease who were receiving antiandrogen therapy and those with psychological diseases. The relationships between the IPSS score and serum sex hormone levels were determined. RESULTS The final study population consisted of 122 men (mean age of 70.66 years), as five were excluded (three due to incomplete evaluation and two who were diagnosed with prostate cancer). On statistical analysis, the total IPSS was significantly associated with age (r = 0.405, P < 0.001) and TT (r = 0.298, P = 0.020) but not with FT or the serum levels of the other sex hormones. The serum levels of testosterone and IPSS did not correlate with prostate volume and Q(max). PSA level and age correlated with prostate volume (r = 0.394, P < 0.001; r = 0.374, P < 0.001, respectively). We distinguished two subgroups of patients: the first group of 40 men with an IPSS of < 19 and the second group of 82 with an IPSS of > 19, and we evaluated the median levels of TT in each group. There was an increased risk of LUTS in men with a greater serum concentration of TT (P = 0.042), although the mean TT level was in the normal range. CONCLUSIONS In the present study, the severity of LUTS was associated with age and serum levels of TT but only age correlated with the measures of BPH, especially prostate volume. The potential effects of testosterone on LUTS may well be indirect. Additional large studies are needed to confirm these preliminary results.
引用
收藏
页码:1700 / 1703
页数:4
相关论文
共 50 条
  • [31] Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors
    Cho, Ahra
    Chughtai, Bilal
    Te, Alexis E.
    CURRENT BLADDER DYSFUNCTION REPORTS, 2020, 15 (02) : 60 - 65
  • [32] The association between anogenital distance and benign prostatic hyperplasia related lower urinary tract symptoms in Chinese aging men
    Yi Lu
    Shujun Fan
    Yuxuan Song
    Kang Liu
    Kechong Zhou
    Jiaqi Kang
    Shangren Wang
    Yongjiao Yang
    Xiaoqiang Liu
    World Journal of Urology, 2021, 39 : 2645 - 2653
  • [33] Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients: Orchestrated by Chronic Prostatic Inflammation and Prostatic Calculi?
    Kim, Sang Hoon
    Jung, Kyu In
    Koh, Jun Sung
    Min, Ki Ouk
    Cho, Su Yeon
    Kim, Hyun Woo
    UROLOGIA INTERNATIONALIS, 2013, 90 (02) : 144 - 149
  • [34] Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia
    Kwon, Jong Kyou
    Han, Jang Hee
    Choi, Ho Chul
    Kang, Dong Hyuk
    Lee, Joo Yong
    Kim, Jae Heon
    Oh, Cheol Kyu
    Choi, Young Deuk
    Cho, Kang Su
    BJU INTERNATIONAL, 2016, 117 (02) : 316 - 322
  • [35] Androgenic Alopecia Is Associated With More Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
    Pazir, Yasar
    Kadihasanoglu, Mustafa
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2024, 16 (05)
  • [36] The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome
    Zhao, Sicong
    Tang, Jianchun
    Shao, Sujun
    Yan, Yong
    UROLOGIA INTERNATIONALIS, 2016, 96 (04) : 449 - 458
  • [37] Metabolic syndrome in the etiology of benign prostatic hyperplasia/lower urinary tract symptoms
    Turker, Polat
    Yazici, Cenk M.
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (04): : 227 - 231
  • [38] Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms
    Kreutzwiser, Denise
    Tseng, Alice
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (10) : 1211 - 1224
  • [39] Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia
    Gallegos, Patrick J.
    Frazee, Lawrence A.
    PHARMACOTHERAPY, 2008, 28 (03): : 356 - 365
  • [40] Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
    Pattanaik, Smita
    Mavuduru, Ravimohan S.
    Panda, Arabind
    Mathew, Joseph L.
    Agarwal, Mayank M.
    Hwang, Eu Chang
    Lyon, Jenifer A.
    Singh, Shrawan K.
    Mandal, Arup K.
    BJU INTERNATIONAL, 2019, 124 (01) : 27 - 34